# Adaptimmune Therapeutics plc (ADAPY)

> Healthcare · GB · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ADAPY/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 21.46M | $ -79.79M | $ -103.87M | $ 48.68M | $ -70.96M |
| 2024 | $ 187.13M | $ -74.43M | $ -79.80M | $ 74.21M | $ 11.85M |
| 2023 | $ 65.18M | $ -123.57M | $ -157.60M | $ 25.24M | $ 39.51M |
| 2022 | $ 30.33M | $ -184.83M | $ -191.59M | $ 23.08M | $ 81.88M |
| 2021 | $ 7.31M | $ -187.92M | $ 2.32M | $ 25.47M | $ 205.96M |
| 2020 | $ 5.04M | $ -165.73M | $ -71.97M | $ 23.71M | $ 341.23M |
| 2019 | $ 1.45M | $ -177.05M | $ -149.19M | $ 25.46M | $ 123.64M |
| 2018 | $ 78.59M | $ -126.59M | $ -144.08M | $ 136.76M | $ 246.89M |
| 2017 | $ 50.97M | $ -94.49M | $ -106.86M | $ 124.22M | $ 202.98M |
| 2016 | $ 19.53M | $ -98.48M | $ -83.86M | $ 0 | $ 166.14M |
| 2015 | $ 18.93M | $ -60.79M | $ -62.10M | $ 0 | $ 234.99M |
| 2014 | $ 6.53M | $ -15.52M | $ 35.30M | $ 0 | $ 91.86M |
| 2013 | $ 0 | $ -7.33M | $ -9.68M | $ 0 | $ -2.30M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.69 |
| Liabilities / Eq | -2.84 |
| Current Ratio | 1.52 |

## Other views

- [Metrics](https://sponda.capital/en/ADAPY.md)
- [Charts](https://sponda.capital/en/ADAPY/charts.md)
- [Compare](https://sponda.capital/en/ADAPY/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.